A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Recruiting · NCT07462377 · Registry updated 2026-09-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, head and neck cancer, head and neck squamous cell carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, squamous cell carcinoma | Recruiting | Phase 1 | 2026-09-10 | NCT07462377 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| EpiBiologics | 1 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| MD Anderson Cancer Center | Houston | United States | 589 |
| Sarah Cannon and HCA Research Institute | Nashville | United States | 4 |
| Site 102 - START San Antonio | San Antonio | United States | 1 |
| Site 104 - START New Jersey | East Brunswick | United States | 1 |
| Site 105 - START Los Angeles | Los Angeles | United States | 1 |
| Site 107 - START New York - Long Island | Lake Success | United States | 1 |